Mirae Asset Sharekhan

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Zenotech Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Zenotech Laboratories Ltd

Fri 15/05/2026,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 45.45

Previous Close

₹ 45.08

Volume

2429

Mkt Cap ( Rs. Cr)

₹274.64

High

₹ 45.45

Low

₹ 44.01

52 Week High

₹ 72.87

52 Week Low

₹ 33.55

Book Value Per Share

₹ 16.09

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Zenotech Laboratories Ltd

Your Vote -

Buy

60.00%

Hold

0.00%

Sell

40.00%

60.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Zenotech Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Zenotech Lab. posts Q4 net loss of Rs 3.15 cr

29 Apr 2026, 4:50PM The company reported standalone net loss during the quarter stood at Rs 3.15 crore compared to net profit of Rs 1.23 crore in the previous year quarte
Zenotech Lab. - Audited Standalone Financial Results For The Quarter And Financial Year Ended March 31, 2026

29 Apr 2026, 4:20PM Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026 and declaration of unmodified opinion on the Financial Re
Zenotech Lab. - Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29, 2026

29 Apr 2026, 4:12PM Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
Zenotech Lab. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

28 Apr 2026, 3:02PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
Zenotech Lab. - Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company Fo

23 Apr 2026, 9:46AM Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to conside
Zenotech Lab. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

17 Apr 2026, 4:50PM As of March 2026, 68.84% is owned by Indian Promoters and 31.16% by Public. <p align=justify> Top Promoter holding highest number of shares of Zenotec
Zenotech Lab. - Clarification On Price Movement

10 Apr 2026, 9:37AM Clarification on Price Movement is enclosed herewith
Zenotech Lab. - Clarification sought from Zenotech Laboratories Ltd

10 Apr 2026, 8:46AM The Exchange has sought clarification from Zenotech Laboratories Ltd on April 9, 2026 with reference to significant movement in price, in order to ens
Zenotech Lab. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

7 Apr 2026, 10:36AM Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
Zenotech Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

12 Mar 2026, 7:27PM Submission of Scrutinizer's Report dated March 12, 2026 for Postal Ballot event.
Zenotech Lab. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

12 Mar 2026, 7:22PM Result of the Postal Ballot by Remote e-Voting process and submission of Scrutinizer's Report dated March 12, 2026.

Key fundamentals

Evaluate the intrinsic value of Zenotech Laboratories Ltd stock

Name	March-26	March-25	March-24	March-23	March-22
Assets	95.1211	96.1308	90.5416	82.2701	76.6401
Liabilities	95.1211	96.1308	90.5416	82.2701	76.6401
Equity	61.0306	61.0306	61.0306	61.0306	61.0306
Gross Profit	9.1885	14.1802	17.2225	20.7035	17.4607
Net Profit	-1.0721	5.6129	8.2987	11.5853	22.1759
Cash From Operating Activities	10.2048	9.4884	11.8226	20.6642	17.6674
NPM(%)	-2.45	13.03	20.32	27.3	60.64
Revenue	43.6136	43.0471	40.8331	42.4243	36.5651
Expenses	34.4251	28.8669	23.6106	21.7208	19.1044
ROE(%)	-1.09	5.71	8.45	11.79	22.58

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	100.00	61.03	61030568.00	10	61.03
2023	2024	Equity Share	100.00	61.03	61030568.00	10	61.03
2022	2023	Equity Share	100.00	61.03	61030568.00	10	61.03
2021	2022	Equity Share	100.00	61.03	61030568.00	10	61.03
2020	2021	Equity Share	100.00	61.03	61030568.00	10	61.03
2019	2020	Equity Share	100.00	61.03	61030568.00	10	61.03
2018	2019	Equity Share	100.00	61.03	61030568.00	10	61.03
2017	2018	Equity Share	100.00	61.03	61030568.00	10	61.03
2016	2017	Equity Share	100.00	34.43	34427500.00	10	34.43
2015	2016	Equity Share	100.00	34.43	34427500.00	10	34.43
2014	2015	Equity Share	100.00	34.43	34427500.00	10	34.43
2013	2014	Equity Share	100.00	34.43	34427500.00	10	34.43
2012	2013	Equity Share	35.00	34.43	34427500.00	10	34.43
2011	2012	Equity Share	35.00	34.43	34427500.00	10	34.43
2010	2011	Equity Share	35.00	34.43	34427500.00	10	34.43
2009	2010	Equity Share	35.00	34.43	34425000.00	10	34.43
2008	2009	Equity Share	35.00	34.43	34425000.00	10	34.43
2007	2008	Equity Share	35.00	34.35	34350000.00	10	34.35
2006	2007	Equity Share	35.00	28.81	28810464.00	10	28.81
2005	2006	Equity Share	35.00	15.68	15682800.00	10	15.68
2004	2005	Equity Share	16.00	14.93	14932800.00	10	14.93
2003	2004	Equity Share	6.00	5.44	5442400.00	10	5.44
2002	2003	Equity Share	6.00	2.32	2319900.00	10	2.32
2001	2002	Equity Share	6.00	2.32	2319900.00	10	2.32
1996	1999	Equity Share	6.00	5.75	5750000.00	10	5.75
1995	1996	Equity Share	6.00	0.87	867000.00	10	0.87

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Zenotech Laboratories Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	723.45	2.67	0.00	25.68	-26.19	0.69
Lotus Eye Hospital and Institute Ltd	107.00	-0.60	343.74	93.58	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	17.37	0.00	0.00	194.31	-39.50	0.00
Astec Lifesciences Ltd	677.75	2.87	0.00	88.25	-363.15	0.00

Company Info

Sunline Tubes Limited was incorporated on 15th June 1989 under the name MAA SHAKTI TUBE MILL PVT LTD under the Companies Act, 1956 and subsequently its name was changed to SUNLINE TUBES PRIVATE LIMITED and Central government's approval obtained vide letter No.RAP/TA-II/1022/Sec.21/92 dated 1st day of April 1992. Later on the Company was converted into a Public Limited Company and a fresh certificate of incorporation was obtained on 25th August, 1993. The Company was originally promoted by Mr.J.K.Chotalia, Mr.J.Goyani, Mr.N.K.Soni, Mr.Dinesh Kumar Soni and their associates. Later on Mr.Sunil Kumar Giri took over the Company in the year 1992. PRESENT BUSINESS OF THE COMPANY The Company was set up for manufacturing of Lancing Tubes and ERW Tubes with an installed capacity of 5000 MTPA. The company has sucessfully completed its trail production. The Company has sucessfully completed its trail production. The Company now plans to expand its existing production Capacity from 5000 MTPA to 34,000 MTPA and expand its product range to include manufacture of higher dia of up to 6". SUBSIDIARIES OF THE COMPANY: The Company does not have any Subsidiary company. 2004 - Re-issues 31,22,500 Equity Shares, which were earlier forfeited by the company due to non-payment of allotment/call monies 2005 - Company has changed its name from Sunline Technologies Ltd. to Zenotech Laboratories Ltd. 2006 -Zenotech Laboratories enters into strategic alliance with the Ranbaxy 2008 -Zenotech Laboratories has Appointed Mr. Atul Sobti, Mr. Omesh Sethi and Mr. Dipak Chattraj as Non-Executive Directors of the Company 2011 -Mr. I Srinivas has been appointed as Company Secretary cum Compliance officer of the company - Dr. Sudershan K. Arora has been appointed as Executive Chairman of the Company. -Registered Office of the Company has been shifted To Survey No. 250-252, Turkapally Village,Shameerpet Mandal,R.R.District -500078,Andhra Pradesh. 2013 - Mr. Chinmoy Patnaik, Company Secretary and Head of Legal of the Company has been appointed as the Compliance Officer of the Company. 2017 -The company issued rights shares of Rs. 10 in the ratio of 17:22 at a premium of Rs. 35 per share.

Sunline Tubes Limited was incorporated on 15th June 1989 under the name MAA SHAKTI TUBE MILL PVT LTD under the Companies Act, 1956 and subsequently its name was changed to SUNLINE TUBES PRIVATE LIMITED and Central government's approval obtained vide letter No.RAP/TA-II/1022/Sec.21/92 dated 1st day of April 1992. Later on the Company was converted into a Public Limited Company and a fresh certificate of incorporation was obtained on 25th August, 1993. The Company was originally promoted by Mr.J.K.Chotalia, Mr.J.Goyani, Mr.N.K.Soni, Mr.Dinesh Kumar Soni and their associates. Later on Mr.Sunil Kumar Giri took over the Company in the year 1992. PRESENT BUSINESS OF THE COMPANY The Company was set up for manufacturing of Lancing Tubes and ERW Tubes with an installed capacity of 5000 MTPA. The company has sucessfully completed its trail production. The Company has sucessfully completed its trail production. The Company now plans to expand its existing production Capacity from 5000 MTPA to 34,000 MTPA and expand its product range to include manufacture of higher dia of up to 6". SUBSIDIARIES OF THE COMPANY: The Company does not have any Subsidiary company. 2004 - Re-issues 31,22,500 Equity Shares, which were earlier forfeited by the company due to non-payment of allotment/call monies 2005 - Company has changed its name from Sunline Technologies Ltd. to Zenotech Laboratories Ltd. 2006 -Zenotech Laboratories enters into strategic alliance with the Ranbaxy 2008 -Zenotech Laboratories has Appointed Mr. Atul Sobti, Mr. Omesh Sethi and Mr. Dipak Chattraj as Non-Executive Directors of the Company 2011 -Mr. I Srinivas has been appointed as Company Secretary cum Compliance officer of the company - Dr. Sudershan K. Arora has been appointed as Executive Chairman of the Company. -Registered Office of the Company has been shifted To Survey No. 250-252, Turkapally Village,Shameerpet Mandal,R.R.District -500078,Andhra Pradesh. 2013 - Mr. Chinmoy Patnaik, Company Secretary and Head of Legal of the Company has been appointed as the Compliance Officer of the Company. 2017 -The company issued rights shares of Rs. 10 in the ratio of 17:22 at a premium of Rs. 35 per share.

Read More

Parent Organisation

Zenotech Laboratories Ltd.

Founded

15/06/1989

Managing Director

NSE Symbol

FAQ

The current price of Zenotech Laboratories Ltd is ₹ 45.00.

The 52-week high for Zenotech Laboratories Ltd is

The market capitalization of Zenotech Laboratories Ltd is currently ₹ 274.64. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Zenotech Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Zenotech Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zenotech Laboratories Ltd shares.

The CEO of Zenotech Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT